Bosh sahifaEKNCF • OTCMKTS
add
Eiken Chemical Co Ltd
Bozor kapitalizatsiyasi
84,06 mlrd JPY
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
TYO
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (JPY) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 10,91 mlrd | 6,67% |
Joriy xarajat | 3,50 mlrd | 10,70% |
Sof foyda | 807,00 mln | -15,32% |
Sof foyda marjasi | 7,40 | -20,60% |
Har bir ulushga tushum | — | — |
EBITDA | — | — |
Amaldagi soliq stavkasi | 28,65% | — |
Balans
Jami aktivlari
Jami passivlari
| (JPY) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 7,87 mlrd | -55,59% |
Jami aktivlari | 63,57 mlrd | -2,49% |
Jami passivlari | 18,20 mlrd | 21,94% |
Umumiy kapital | 45,37 mlrd | — |
Tarqatilgan aksiyalar | 34,18 mln | — |
Narxi/balansdagi bahosi | — | — |
Aktivlardan daromad | 4,23% | — |
Kapitaldan daromad | 5,47% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (JPY) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 807,00 mln | -15,32% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Eiken Chemical is a Japanese company headquartered in Tokyo, established in 1939. The company's business is manufacturing and sales of clinical diagnostics and equipment.
Eiken's major products include fecal immunochemical test reagents, immunological and serological reagents, microbiological reagents, urinalysis test strips, clinical chemistry reagents, molecular genetics, medical devices and industrial products.
The company in 1998 developed the Loop-mediated isothermal amplification method, a nucleic acid amplification method, which is one of the most valuable tools in virtually all life science fields. Wikipedia
Tashkil etilgan
20-fev, 1939
Sayt
Xodimlar soni
757
